BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 12661373)

  • 1. [Histopathologic prognostic factors, serum markers and selected molecular biologic factors in ovarian carcinoma].
    Spacek J; Jílek P; Petera J; Tesarík Z
    Ceska Gynekol; 2002 Nov; 67(6):343-9. PubMed ID: 12661373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Importance of clinical prognostic factors in the treatment of ovarian carcinoma].
    Spacek J; Petera J; Tesarík Z
    Ceska Gynekol; 2002 Sep; 67(5):280-5. PubMed ID: 12434665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prognostic factors of mesenchymal and mixed tumors of uterus].
    Spacek J; Laco J; Petera J; Jílek P; Krepinská E; Rezác A; Stipl S
    Ceska Gynekol; 2009 Aug; 74(4):292-7. PubMed ID: 20564985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Para-aortic lymphadenectomy in gynecology. Theoretical principles, basic approach and practical suggestions].
    Spacek J; Veselský Z; Tosner J; Tesarík Z
    Ceska Gynekol; 2003 Mar; 68(2):99-105. PubMed ID: 12749178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Proteomics and biomarkers for detection of ovarian cancer].
    Kacerovský M; Tambor V; Lenco J; Tosner J
    Ceska Gynekol; 2009 Jun; 74(3):163-70. PubMed ID: 19642513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Recurrent vulvovaginal candidiasis--possibility of its treatment].
    Spacek J; Buchta V; Jílek P; Krejsek J; Pidrman V; Kalousek I; Matula V; Kestránek J; Drahosová M; Vejsová M; Forstl M
    Ceska Gynekol; 2008 Jun; 73(3):179-84. PubMed ID: 18646671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prognostic factors of ovarian cancer].
    Jancárková N; Krkavcová M; Janashia M; Freitag P
    Ceska Gynekol; 2006 May; 71(3):252-9. PubMed ID: 16768055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Vulvodynia and the possibility of its management].
    Kestránek J; Matula V; Pidrman V; Taláb R; Jílek P; Buchta V; Spacek J
    Ceska Gynekol; 2010 Dec; 75(6):521-6. PubMed ID: 27534008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antifungal immunity and its mechanism in female genitalia].
    Spacek J; Jílek P; Buchta V; Drahosová M; Förstl M; Kalousek I
    Ceska Gynekol; 2004 Mar; 69(2):133-40. PubMed ID: 15141525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Radiotherapy in the treatment of ovarian epithelial carcinoma].
    Petera J; Spacek J; Odrázka K
    Ceska Gynekol; 2003 Jul; 68(4):264-9. PubMed ID: 14515650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of immunohistochemistry in prognostic assessment of epithelial ovarian carcinoma --review of the literature I.
    Tomsová M; Melichar B
    Acta Medica (Hradec Kralove); 2006; 49(3):161-5. PubMed ID: 17117604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Systemic immunity in patients with recurrent vulvovaginal candidiasis].
    Jílek P; Spacek J; Buchta V; Kucera Z; Drahosová M; Förstl M; Andrýs C
    Ceska Gynekol; 2005 Nov; 70(6):453-9. PubMed ID: 17955799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Vascular endothelial growth factor in ovarian cancer patients].
    Sedláková I; Tošner J; Kopecký O; Vroblová V; Rezáč A; Skapinec P; Andrýs C
    Ceska Gynekol; 2012 Oct; 77(5):415-20. PubMed ID: 23116346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Microbiological findings in patients with recurrent vulvovaginal candidiasis in the Hradec Králové Faculty Hospital 1995-2002].
    Buchta V; Spacek J
    Ceska Gynekol; 2004 Jan; 69(1):7-14. PubMed ID: 15112380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A new opportunity in ovarian cancer treatment].
    Sedláková I
    Ceska Gynekol; 2012 Oct; 77(5):469-71. PubMed ID: 23116353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biologic prognostic factors in ovarian cancer: a review.
    Framarino dei Malatesta ML; Veneziano M; Peppicelli M; Lanzi G; Marzetti L
    Eur J Gynaecol Oncol; 1998; 19(2):123-5. PubMed ID: 9611049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Matrix-producing breast carcinoma with myoepithelial differentiation--description of 11 cases and review of literature aimed at histogenesis and differential diagnosis].
    Kinkor Z; Boudová L; Ryska A; Kajo K; Svec A
    Ceska Gynekol; 2004 May; 69(3):229-36. PubMed ID: 15310000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chemoresistance/Chemosensitivity of ovarian cancer--a case report].
    Sedláková I; Tosner J; Rezác A; Cervinka M; Tomsová M; Spacek J
    Ceska Gynekol; 2008 Jun; 73(3):140-3. PubMed ID: 18646664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Proteomics and biomarkers for detection of endometrial carcinoma].
    Kacerovský M; Tosner J
    Ceska Gynekol; 2009 Aug; 74(4):274-8. PubMed ID: 20564981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Importance of chromosomal changes correlated to prognostic factors in ovarian and cervical malignant tumors].
    Jancárková N; Krkavcová M; Janashia M; Freitag P; Dusková J; Cibula D
    Ceska Gynekol; 2008 Apr; 73(2):79-86. PubMed ID: 18567425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.